首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >DEVELOPMENT AND METHOD VALIDATION USING HPLC FOR ASSAY OF ZIPRASIDONE CAPSULE
【24h】

DEVELOPMENT AND METHOD VALIDATION USING HPLC FOR ASSAY OF ZIPRASIDONE CAPSULE

机译:高效液相色谱法测定齐拉西酮胶囊的开发及方法验证

获取原文
           

摘要

reverse phase HPLC method is described for the determination of Ziprasidone HCl capsule by analytical method. Chromatography was carried out on an ODS C18 column using a mixture of buffer solution, acetonitrile and methanol (45: 40: 15v/v/v) as the mobile phase at a flow rate of 1.5mL/min. Detection was carried out at 230nm. The retention time of the drug was 7-9 min. The method produced linear responses in the concentration range of 50-150|ìg/mL of Ziprasidone .The method was found to be applicable for determination of the drug in capsules
机译:反相高效液相色谱法用于分析盐酸齐普拉西酮胶囊的测定。使用缓冲溶液,乙腈和甲醇的混合物(45:40:15v / v / v)作为流动相,在ODS C18色谱柱上进行色谱分离,流速为1.5mL / min。在230nm处进行检测。药物的保留时间为7-9分钟。该方法在Ziprasidone浓度范围为50-150 |ìg/ mL时产生线性响应。该方法适用于胶囊中药物的测定

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号